Search Results - "Choong, David Y H"

Refine Results
  1. 1

    Mutation of the PIK3CA gene in ovarian and breast cancer by CAMPBELL, Ian G, RUSSELL, Sarah E, CHOONG, David Y. H, MONTGOMERY, Karen G, CIAVARELLA, Marianne L, HOOI, Christine S. F, CRISTIANO, Briony E, PEARSON, Richard B, PHILLIPS, Wayne A

    Published in Cancer research (Chicago, Ill.) (01-11-2004)
    “…Phosphatidylinositol 3'-kinases are lipid kinases with important roles in neoplasia. Recently, a very high frequency of somatic mutations in PIK3CA has been…”
    Get full text
    Journal Article
  2. 2
  3. 3

    High-Resolution Single Nucleotide Polymorphism Array Analysis of Epithelial Ovarian Cancer Reveals Numerous Microdeletions and Amplifications by GORRINGE, Kylie L, JACOBS, Sharoni, THOMPSON, Ella R, SRIDHAR, Anita, WEN QIU, CHOONG, David Y. H, CAMPBELL, Lan G

    Published in Clinical cancer research (15-08-2007)
    “…Purpose: Genetic changes in sporadic ovarian cancer are relatively poorly characterized compared with other tumor types. We have evaluated the use of…”
    Get full text
    Journal Article
  4. 4

    Differential hypermethylation of SOCS genes in ovarian and breast carcinomas by SUTHERLAND, Kate D, LINDEMAN, Geoffrey J, CHOONG, David Y. H, WITTLIN, Sergio, BRENTZELL, Luci, PHILLIPS, Wayne, CAMPBELL, Ian G, VISVADER, Jane E

    Published in Oncogene (07-10-2004)
    “…Suppressor of cytokine signaling (SOCS) proteins have emerged as critical attenuators of cytokine-mediated processes, suggesting a role in the suppression of…”
    Get full text
    Journal Article
  5. 5

    MicroRNA genes and their target 3'-untranslated regions are infrequently somatically mutated in ovarian cancers by Ryland, Georgina L, Bearfoot, Jennifer L, Doyle, Maria A, Boyle, Samantha E, Choong, David Y H, Rowley, Simone M, Tothill, Richard W, Gorringe, Kylie L, Campbell, Ian G

    Published in PloS one (20-04-2012)
    “…MicroRNAs are key regulators of gene expression and have been shown to have altered expression in a variety of cancer types, including epithelial ovarian…”
    Get full text
    Journal Article
  6. 6

    Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors by Arnold, Jeremy M, Choong, David Y. H, Thompson, Ella R, Waddell, Nic, Lindeman, Geoffrey J, Visvader, Jane E, Campbell, Ian G, Chenevix-Trench, Georgia

    Published in Breast cancer research and treatment (01-01-2010)
    “…Heterozygous somatic mutations of the transcription factor, GATA-3, have recently been reported in approximately 5% breast of tumors unselected for family…”
    Get full text
    Journal Article
  7. 7

    Analysis of KLLN as a high-penetrance breast cancer predisposition gene by Thompson, Ella R., Gorringe, Kylie L., Choong, David Y. H., Eccles, Diana M., Mitchell, Gillian, Campbell, Ian G.

    Published in Breast cancer research and treatment (01-07-2012)
    “…KLLN is a p53 target gene with DNA binding function and represents a highly plausible candidate breast cancer predisposition gene. We screened for predisposing…”
    Get full text
    Journal Article
  8. 8

    BARD1 variants are not associated with breast cancer risk in Australian familial breast cancer by Gorringe, Kylie L., Choong, David Y. H., Visvader, Jane E., Lindeman, Geoffrey J., Campbell, Ian G.

    Published in Breast cancer research and treatment (01-10-2008)
    “…Several studies in various populations have suggested that non-synonymous BARD1 variants are associated with increased breast cancer risk. Using DHPLC analysis…”
    Get full text
    Journal Article
  9. 9

    Loss of heterozygosity: what is it good for? by Ryland, Georgina L, Doyle, Maria A, Goode, David, Boyle, Samantha E, Choong, David Y H, Rowley, Simone M, Li, Jason, Bowtell, David D L, Tothill, Richard W, Campbell, Ian G, Gorringe, Kylie L

    Published in BMC medical genomics (01-08-2015)
    “…Loss of heterozygosity (LOH) is a common genetic event in cancer development, and is known to be involved in the somatic loss of wild-type alleles in many…”
    Get full text
    Journal Article
  10. 10

    Analysis of the mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer by Davis, Sally J, Choong, David Y H, Ramakrishna, Manasa, Ryland, Georgina L, Campbell, Ian G, Gorringe, Kylie L

    Published in BMC cancer (17-05-2011)
    “…MAP2K4 is a putative tumor and metastasis suppressor gene frequently found to be deleted in various cancer types. We aimed to conduct a comprehensive analysis…”
    Get full text
    Journal Article
  11. 11

    Breast cancer risk and the BRCA1 interacting protein CTIP by Gorringe, Kylie L., Choong, David Y. H., Lindeman, Geoffrey J., Visvader, Jane E., Campbell, Ian G.

    Published in Breast cancer research and treatment (01-11-2008)
    “…Mutations in BRCA1 predispose to breast cancer. CTIP interacts with BRCA1 and so could also be associated with increased risk. We screened CTIP for germline…”
    Get full text
    Journal Article
  12. 12

    Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients by Thompson, Ella R., Boyle, Samantha E., Johnson, Julie, Ryland, Georgina L., Sawyer, Sarah, Choong, David Y.H., kConFab, Chenevix-Trench, Georgia, Trainer, Alison H., Lindeman, Geoffrey J., Mitchell, Gillian, James, Paul A., Campbell, Ian G.

    Published in Human mutation (01-01-2012)
    “…There is strong evidence that overtly inactivating mutations in RAD51C predispose to hereditary breast and ovarian cancer but the prevalence of such mutations,…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Genetic and Epigenetic Analysis of the Putative Tumor Suppressor km23 in Primary Ovarian, Breast, and Colorectal Cancers by CAMPBELL, Ian G, PHILLIPS, Wayne A, CHOONG, David Y. H

    Published in Clinical cancer research (15-06-2006)
    “…Purpose: A very high frequency of somatic mutations in the transforming growth factor-β signaling component km23 has been reported in a small series of ovarian…”
    Get full text
    Journal Article
  15. 15

    No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer by Campbell, Ian G, Eccles, Diana M, Choong, David Y.H.

    Published in Cancer letters (28-08-2006)
    “…A functional T to G germline polymorphism in the promoter region of MDM2 (SNP309) has been reported to profoundly accelerate tumor formation suggesting that it…”
    Get full text
    Journal Article
  16. 16

    Genetic Analysis of Cancer-Implicated MicroRNA in Ovarian Cancer by BEARFOOT, Jennifer L, CHOONG, David Y. H, GORRINGE, Kylie L, CAMPBELL, Lan G

    Published in Clinical cancer research (15-11-2008)
    “…Purpose: There is accumulating evidence that microRNAs may function like classic tumor suppressor genes but little is known about their mechanism of…”
    Get full text
    Journal Article
  17. 17

    Copy number analysis of ductal carcinoma in situ with and without recurrence by Gorringe, Kylie L, Hunter, Sally M, Pang, Jia-Min, Opeskin, Ken, Hill, Prue, Rowley, Simone M, Choong, David Y H, Thompson, Ella R, Dobrovic, Alexander, Fox, Stephen B, Mann, G Bruce, Campbell, Ian G

    Published in Modern pathology (01-09-2015)
    “…Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive breast cancer and a frequent mammographic finding requiring treatment. Up to 25% of…”
    Get full text
    Journal Article
  18. 18

    Transforming Growth Factor β Receptor 1 Polyalanine Polymorphism and Exon 5 Mutation Analysis in Breast and Ovarian Cancer by BAXTER, Simon W, CHOONG, David Y. H, ECCLES, Diana M, CAMPBELL, Ian G

    “…The inactivation or altered expression of TGF-β receptors or other components of the TGF-β signaling pathway are common in many cancer types. A germ-line…”
    Get full text
    Journal Article
  19. 19

    Genetic and epigenetic analysis of the TIMP-3 gene in ovarian cancer by Liu, Mira C.P, Choong, David Y.H, Hooi, Christine S.F, Williams, Louise H, Campbell, Ian G

    Published in Cancer letters (08-03-2007)
    “…Abstract Chromosome 22q shows a high frequency of loss of heterozygosity (LOH) in ovarian cancers suggesting the existence of one or more important tumor…”
    Get full text
    Journal Article
  20. 20